Position in ALKS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,485
+$310 QoQ
Shares Held
42
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026PICTON MAHONEY ASSET MANAGEMENT holds $42,116,858 across 13 Drug Manufacturers - Specialty & Generic names. ALKS ranks #8 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
810,218 | $24,403,766 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
698,688 | $16,719,603 | |
| 3 | BHC |
Bausch Health Companies Inc.
|
181,539 | $980,310 | |
| 4 | SUPN |
Supernus Pharmaceuticals, Inc.
|
36 | $1,860 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
3 | $1,778 | |
| 6 | AMRX |
Amneal Pharmaceuticals, Inc.
|
133 | $1,653 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
20 | $1,538 | |
| 8 | ALKS |
Alkermes plc.
This page
|
42 | $1,485 |
All Filings in ALKS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,485 | 42 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,175 | 42 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,260 | 42 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,201 | 42 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,386 | 42 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $1,207 | 42 | Shares | Sole | 2025-04-02 | |
| 2024-09-30 | $1,175 | 42 | Shares | Sole | 2024-11-04 | |
| No filing history on record for this holder in this stock. | ||||||